Category Archives: Canagliflozin

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at the plant where it is manufactured are fixed.

The delay does not call into question the safety or utility of …

Type 2 Drugs in the Pipeline: an Update

If you Google “type 2 diabetes drugs,” one website lists the names of 92 drugs that medical professionals have prescribed at one time or another to treat diabetes.

You’d think that the diabetes apothecary has a more than a sufficient …